Physician
Rosenberg, Sharon
Rosenberg, Sharon was paid $356K by Medicaid between Jan 2018 and Dec 2022, across 14 billing codes. Its largest line is S9083, Global fee urgent care centers — 31% of everything it billed.
33Billing provider infoROSENBERG, SHARON
MIDDLETOWN, NY 10941
MIDDLETOWN, NY 10941
33aNPI1427030675assigned 11/15/2005
33bProvider typeFamily Medicine Physician
28Total paid$356K
24GClaims3,522
24DCodes billed14
24AFirst – last monthJan 2018 – Dec 2022
Compared with peers
Next to other Family Medicine Physician providers in New York
Rank by total paid#279 of 2,605
Median peer was paid$10K
This provider vs. median35×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 246 | $17K | |
| 2019 | 615 | $49K | |
| 2020 | 616 | $55K | |
| 2021 | 796 | $89K | |
| 2022 | 1,249 | $145K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| S9083 | Global fee urgent care centers | 31% | 733 | 729 | $110K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 28% | 1,117 | 1,110 | $98K |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | 20% | 540 | 535 | $71K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 19% | 927 | 919 | $67K |
| 87631 | 1.3% | 36 | 36 | $5K | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 25 | 25 | $2K |
| 87634 | <1% | 13 | 13 | $912.60 | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 32 | 32 | $761.30 |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 12 | 12 | $421.08 |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 25 | 25 | $332.82 |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 13 | 13 | $300.00 |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 25 | 24 | $181.29 |
2 more codes
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.